Skip to main content

Peer Review reports

From: Cost-effectiveness of the anti-fibrotics for the treatment of idiopathic pulmonary fibrosis in the United States

Original Submission
10 Sep 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
16 Oct 2021 Reviewed Reviewer Report - Harold R Collard
18 Oct 2021 Reviewed Reviewer Report
17 Nov 2021 Author responded Author comments - Timothy M. Dempsey
Resubmission - Version 3
17 Nov 2021 Submitted Manuscript version 3
12 Dec 2021 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
13 Dec 2021 Editorially accepted
10 Jan 2022 Article published 10.1186/s12890-021-01811-0

You can find further information about peer review here.

Back to article page